Loading...
Market
Story
Japan's PHDP5 Peptide Reverses Alzheimer’s Symptoms in Mice
Jun 24, 2024, 02:01 PM
Researchers at the Okinawa Institute of Science and Technology (OIST) in Japan have developed a synthetic peptide, PHDP5, that successfully reversed Alzheimer’s symptoms in mice. The peptide targets and improves brain synaptic function, effectively restoring cognitive function and memory by reversing synapse damage. Treated mice exhibited the same cognitive function as healthy mice, highlighting the potential of PHDP5 to cross the blood-brain barrier and offer a new therapeutic approach for Alzheimer’s disease.
View original story
Similar markets
United States • 25%
European Union • 25%
South Korea • 25%
Other • 25%
Russia • 25%
Europe (excluding Russia) • 25%
North America • 25%
Asia (excluding Russia) • 25%
Canada • 25%
Australia • 25%
Germany • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Canada • 25%
Other • 25%
0-1 • 25%
2-5 • 25%
6-10 • 25%
More than 10 • 25%
United States • 25%
European Union • 25%
Asia-Pacific • 25%
Other regions • 25%
United States • 25%
European Union • 25%
Africa • 25%
Other • 25%
Yes • 50%
No • 50%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
United States • 25%
European Union • 25%
Japan • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%